July 23, 2025

Are Wearables Mining the Mind?

As neurotech devices move from clinics to consumers, states are racing to safeguard brainwave data from earbuds, sleep trackers, and AI-powered apps—raising new questions about privacy, consent, and medical ethics.

KFF Health News

July 10, 2025

Cochlear Implants Linked to Greater Social Quality-of-Life Gains

Researchers find that hearing aids and cochlear implants improve social quality of life and reduce perceived social handicap in adults with hearing loss.

Conexiant

January 16, 2025

Vertigo, Emesis, Auditory Impairment: What's Your Diagnosis?

A patient presents with sudden-onset right-sided otalgia accompanied by vertigo, emesis, and auditory impairment. Your otoscope reveals an unexpected finding. What's your diagnosis?

Conexiant

February 10, 2025

Research Links mTBI in Trauma to PTSD and Symptoms

Veterans with peritraumatic mTBI reported greater PTSD severity and disability, study finds.

Conexiant

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

February 27, 2025

Study Finds EVT Does Not Improve Stroke Recovery

EVT did not confer a functional benefit in patients with medium-vessel occlusion stroke, according to key findings from the ESCAPE-MeVO trial.

Conexiant

September 18, 2024

Do Hydrocephalus Shunts Pose Less Pregnancy Risk Than Once Thought?

A 2024 study of 85 pregnancies found no shunt malfunctions during pregnancy and only a 5.9% postpartum revision rate, contradicting decades of data on shunt failure risks for pregnant women.

Conexiant

January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

June 10, 2025

Cancer Pain Study Shows Promise for Novel Neurotoxin

A Phase I study of intrathecal resiniferatoxin in patients with advanced cancer pain shows promising reductions in pain and opioid use, with durable effects and manageable side effects.

Conexiant